Guardant Health
291 hedge funds and large institutions have $2.53B invested in Guardant Health in 2022 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 90 increasing their positions, 101 reducing their positions, and 87 closing their positions.
413% more call options, than puts
Call options by funds: $111M | Put options by funds: $21.6M
1.06% less ownership
Funds ownership: 91.77% → 90.71% (-1.1%)
11% less repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 101
11% less funds holding
Funds holding: 327 → 291 (-36)
34% less first-time investments, than exits
New positions opened: 57 | Existing positions closed: 87
49% less capital invested
Capital invested by funds: $4.98B → $2.53B (-$2.46B)
86% less funds holding in top 10
Funds holding in top 10: 7 → 1 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$81.6M |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$77.7M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$36.6M |
| 4 |
Millennium Management
New York
|
+$27.2M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$20.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Holocene Advisors
New York
|
-$59.2M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$57.7M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$53.4M |
| 4 |
JP Morgan Chase
New York
|
-$37.2M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$31.3M |
GH Hedge Fund Activity: Q4 2022 in Review
291 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q4 2022, worth a combined $2.53B — down 49% from $4.98B a quarter earlier.
Sellers outnumbered buyers: 87 funds closed out of GH and 57 opened new positions — a net loss of 30 holders — while 101 trimmed existing stakes and 90 added.
The largest buyer was AllianceBernstein, adding an estimated $81.6M. The largest seller was Holocene Advisors, exiting entirely with an estimated $59.2M sold.
- 291 institutional investors held Guardant Health (GH) as of Q4 2022, down from 327 in Q3 2022.
- Funds reported $2.53B of Guardant Health stock for Q4 2022, down 49% quarter-over-quarter.
- 57 funds opened new Guardant Health positions in Q4 2022 and 87 closed out, a net change of -30 holders.
- The largest Guardant Health buyer in Q4 2022 was AllianceBernstein, an estimated $81.6M added.
- The largest Guardant Health seller in Q4 2022 was Holocene Advisors, an estimated $59.2M sold.
Based on aggregated 13F filings for Q4 2022.